跳至主要内容
临床试验/NCT05011071
NCT05011071Enrolling By Invitation不适用

The Alberta BLOOM Premature Child Study: Impact of the Microbiome on the Clinical Course and Health Outcomes of Premature Children

University of Calgary1 个研究点 分布在 1 个国家目标入组 535 人开始时间: 2021年10月21日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
535
试验地点
1
主要终点
Infant outcomes at 1 and 3 years of age

研究概览

简要总结

This is a prospective, observational clinical cohort study involving 405 children born premature (at less than 37 weeks gestation) and their mother/parent/guardian. The purpose of the study is to investigate how the microbiome (the collection of microbes in a biological site) of children develops over the first years of life and its associations with the risk of childhood health outcomes including allergies and asthma. The study will also examine how perinatal factors associate with patterns of microbiome development, and their effects on the microbiome, metabolome (the collection of metabolites in a biological sample) and immune development of this population in the first years of life.

详细描述

Premature birth (birth before 37 weeks of pregnancy) occurs in about 1 in 10 pregnancies. When infants are born prematurely their gut is not as developed. One important factor in gut health is the large community of microbes (tiny living things such as bacteria) that live on the human body called the microbiome. Recent studies have shown that premature infants are more likely to experience changes to their gut microbiome that are associated with health issues, such as asthma and allergies. However, the specific microbiome features of children born preterm and the role of their microbiome in disease risk and childhood health is not well understood. The Alberta BLOOM Premature Child Study (PCS) investigates how the microbiome and immune health of premature children develops over the first years of life and its associations with the risk of childhood health outcomes. BLOOM-PCS will also study how the microbiome of children born premature differs from the microbiome in the term population.

The type of microbes that are present in the infant's gut in the first months of life have a major impact on the microbiome that will form during childhood. There are many environmental factors during pregnancy, birth and the first months of life that can impact an infant's microbiome development. Factors such as diet, exposure to antibiotics, surgical procedures, and mode of delivery can strongly affect early microbiome development. This study will investigate how these factors influence the types of early microbes present in preterm infants.

This study hypothesizes that specific microbial patterns, trajectories and/or metabolites will be significantly associated with single or a combination of perinatal maternal and/on infant factors. Also, that microbial alterations resulting from preterm birth contributes to the allergy and asthma outcomes in infants through immune mechanisms.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
0 Days 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Less than 8 days of age or previous participation in one of the BLOOM-PTN, BLOOM-LTFU, Pregnancy During the Pandemic or PROBIO studies;
  • Born at ≤ 36 weeks + 6 days gestation (36 6/7 weeks gestational age)
  • For babies recruited shortly after birth, be expected to survive more than one week;
  • Mother/Parent/Legal Guardian Inclusion Criteria:
  • Provide a signed and dated consent form;
  • Be able to speak and understand English;
  • Be 16 years of age or older;
  • Be willing to comply with all study procedures and be available for the duration of the study;
  • If recruited as a previous participant of the BLOOM-PTN, BLOOM-LTFU, Pregnancy During the Pandemic and/or PROBIO studies, must be willing to attend clinic visit(s) at the Alberta Children's Hospital in Calgary, Alberta at 1 and 3 years Corrected Gestational Age, or
  • If recruited within 8 days of birth, must reside within the Calgary Metropolitan Region.
  • Exclusion Criteria

排除标准

  • Has major congenital or chromosomal anomalies, including any congenital gastrointestinal anomalies
  • Children recruited within 8 days of birth who have a history of gastrointestinal surgery at the time of recruitment
  • Mother/Parent/Legal Guardian Exclusion Criteria:
  • Not the legal guardian of the child or
  • In a legal guardianship dispute.

结局指标

主要结局

Infant outcomes at 1 and 3 years of age

时间窗: 1-3.5 Years Corrected Gestational Age

Infant outcomes as assessed by the Asthma Predictive Index, a validated methodology that helps predict asthma in young children by determining history of wheeze, atopic dermatitis, familial history and eosinophilia, and skin reactivity to common allergens via a skin prick test.

次要结局

  • Metabolome(0-3.5 Years Corrected Gestational Age)
  • Perinatal factors and microbiome, metabolome and immunobiome(0-3.5 Years Corrected Gestational Age)
  • Microbiome(0-3.5 Years Corrected Gestational Age)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marie-Claire Arrieta

Assistant Professor

University of Calgary

研究点 (1)

Loading locations...

相似试验

The Alberta BLOOM Premature Child Study | 临床试验